SSIM
HRMY icon

Sheets Smith Investment Management’s Harmony Biosciences HRMY Stock Holding History

Sheets Smith Investment Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$544K Buy
+11,367
New +$625K 0.6% 24
2022
Q2 		$559K Buy
+11,884
New +$535K 0.65% 28

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Sheets Smith Investment Management's HRMY Position: Q4 2022 in Review

Sheets Smith Investment Management opened a new position in Harmony Biosciences (HRMY) in Q4 2022: 11,367 shares worth $544K. The stake represents 0.6% of the portfolio and ranks #24 among its holdings. This is a return to the name: Sheets Smith Investment Management previously reported a position in HRMY as recently as Q2 2022.

Sheets Smith Investment Management first reported a position in HRMY in Q2 2022 and has held it in 2 quarters since. The position peaked at $559K in Q2 2022. 242 funds tracked by Wall St. Rank hold HRMY as of Q4 2022.

  • Sheets Smith Investment Management held 11,367 shares of Harmony Biosciences worth $544K as of Q4 2022.
  • Harmony Biosciences was a new Sheets Smith Investment Management position in Q4 2022.
  • Harmony Biosciences made up 0.6% of Sheets Smith Investment Management's portfolio in Q4 2022, its #24 holding.
  • Sheets Smith Investment Management first reported a position in Harmony Biosciences in Q2 2022 and has held it in 2 quarters since.
  • Sheets Smith Investment Management's Harmony Biosciences position peaked at $559K in Q2 2022.
  • 242 funds tracked by Wall St. Rank held Harmony Biosciences as of Q4 2022.

Based on Sheets Smith Investment Management's 13F filing for Q4 2022, filed 10 Feb 2023.